Literature DB >> 12003604

Management of vitreoretinal complications in eyes with permanent keratoprosthesis.

Subhransu Ray1, Bilal F Khan, Claes H Dohlman, Donald J D'Amico.   

Abstract

OBJECTIVES: To evaluate the spectrum and treatment of posterior segment complications in eyes that had undergone successful keratoprosthesis (KPro) placement and to determine whether transeyelid vitrectomy techniques could be effectively used in eyes otherwise vulnerable to surface exposure.
DESIGN: In the last 10 years, 110 patients received a Dohlman-Doane KPro at the Massachusetts Eye and Ear Infirmary, Boston. We evaluated 22 eyes in 18 patients that required subsequent vitreoretinal surgery to treat posterior segment complications. One surgeon using modified vitreoretinal techniques, as described below, performed all vitreoretinal procedures.
RESULTS: The posterior segment complications included 6 cases of retro-KPro membranes, 13 cases of retinal detachments, and 5 cases of isolated vitreous opacity. All 6 retro-KPro membranes were effectively removed by vitrectomy without significant complication and 3 of these patients enjoyed improvement of visual acuity of at least 5 Snellen lines. Of 13 cases of retinal detachment, 6 patients had some improvement in visual acuity, 5 showed no appreciable change, and 2 had some decline in the final visual acuity. In all 5 cases of isolated vitreous opacity, the media was effectively cleared with pars plana vitrectomy. Three patients enjoyed improvement of visual acuity of at least 3 Snellen lines. Four cases of transeyelid vitrectomy were attempted and anatomical success was achieved in all 4 and vision improved in 3 of these patients. No special surgical complications were encountered in any of the 22 eyes as a result of these modified surgical techniques. MAIN OUTCOME MEASURES: Best preoperative and postoperative visual acuity and anatomical success were evaluated in relation to the preoperative posterior segment complication.
CONCLUSIONS: Modified vitreoretinal surgical techniques can be effectively and safely used to treat posterior segment complications in patients with KPro devices. Retro-KPro membranes and other vitreous opacities were the most amenable to treatment. Retinal complications posed a special challenge. However, all of these cases highlight that modified vitrectomy techniques can be used in eyes with permanent KPro devices. These techniques can be performed without additional risk to the eye. Additionally, we demonstrated that transeyelid vitrectomy techniques could be used effectively to manage complications in eyes with severe ocular surface disease without undue exposure of vulnerable tissues.

Entities:  

Mesh:

Year:  2002        PMID: 12003604     DOI: 10.1001/archopht.120.5.559

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Boston keratoprosthesis type 1: outcomes of the first 38 cases performed at Moorfields Eye Hospital.

Authors:  Chameen Samarawickrama; Nicholas Strouthidis; Mark R Wilkins
Journal:  Eye (Lond)       Date:  2018-02-14       Impact factor: 3.775

3.  Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients.

Authors:  E J Hollick; S L Watson; J K G Dart; P J Luthert; B D S Allan
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

4.  Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.

Authors:  J L Alió; M E Mulet; H Haroun; J Merayo; J M Ruiz Moreno
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

5.  Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts.

Authors:  Alireza Ghaffariyeh; Nazafarin Honarpisheh; Akbar Karkhaneh; Reza Abudi; Zinaida Ivanovna Moroz; Alireza Peyman; Abolhasan Faramarzi; Fuad Abasov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-27       Impact factor: 3.117

6.  Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases.

Authors:  Ilias Georgalas; Anastasios J Kanelopoulos; Petros Petrou; Ioannis Ladas; Eustratios Gotzaridis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-12       Impact factor: 3.117

7.  COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.

Authors:  Jennifer I Lim; Lindsay Machen; Andrea Arteaga; Faris I Karas; Robert Hyde; Dingcai Cao; Marcia Niec; Thasarat S Vajaranant; M Soledad Cortina
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

8.  Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes.

Authors:  Maria Stephanie R Jardeleza; Marc-Andre Rheaume; James Chodosh; Anne Marie Lane; Claes H Dohlman
Journal:  Digit J Ophthalmol       Date:  2015-12-21

9.  [Results with the Boston keratoprosthesis].

Authors:  B Koller; T Neuhann; I Neuhann
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

10.  Pars plana vitrectomy through the Boston Keratoprosthesis type 1.

Authors:  M Harissi-Dagher; G M Durr; K Biernacki; M Sebag; M-A Rhéaume
Journal:  Eye (Lond)       Date:  2013-04-12       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.